Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes

被引：0
|
作者：
List, J. F. [1 ]
Woo, V. [2 ]
Morales, E. [3 ]
Tang, W. [1 ]
Fiedorek, F. T. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Hlth Sci Ctr, Diabet Res & Treatment Ctr, Winnipeg, MB, Canada
[3] Ctr Invest Cardiometab, Aguascalientes, Mexico
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [31] Safety and Efficacy of Fingolimod in Treatment-Naive Multiple Sclerosis Patients
    Marriott, James J.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 43 - 50
  • [32] Safety and efficacy of pramipexole in early Parkinson disease - A randomized dose-ranging study
    Kieburtz, K
    Shoulson, I
    McDermott, M
    Fahn, S
    Lang, A
    Olanow, W
    Penney, J
    Wooten, GF
    Kurlan, R
    Gardiner, I
    Petzinger, G
    Brin, M
    Dillon, S
    Shannon, K
    Jaglin, JA
    Trosch, R
    Mistura, K
    Harrison, M
    RostRuffner, E
    Tanner, C
    Singer, C
    Weiner, W
    Sheldon, C
    Grimes, JD
    Gray, P
    Hurtig, H
    Hauser, R
    Gauger, L
    Rajput, A
    Rudnitzky, R
    Dobson, J
    Panisset, M
    Gauthier, S
    Amyot, D
    Perlmutter, J
    Hubble, J
    Barter, R
    Suchowersky, O
    Lew, M
    Welsh, M
    Marek, K
    Fussell, B
    Sethi, K
    Ligon, K
    Rao, J
    Rudolph, A
    Casaceli, C
    Day, D
    Johnston, K
    Baker, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (02): : 125 - 130
  • [33] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
  • [34] Efficacy of naratriptan tablets in the acute treatment of migraine:: A dose-ranging study
    Havanka, H
    Dahlöf, C
    Pop, PHM
    Diener, HC
    Winter, P
    Whitehouse, H
    Hassani, H
    CLINICAL THERAPEUTICS, 2000, 22 (08) : 970 - 980
  • [35] Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin
    Wilding, J. P. H.
    Leonsson-Zachrisson, M.
    Wessman, C.
    Johnsson, E.
    DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 750 - 759
  • [36] Safety and efficacy of Dapagliflozin type 2 diabetes mellitus patients during fasting
    Fatima, N.
    Baloch, A. Ali
    Kiran, Z.
    Shabbir, K. U.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [37] Real-World Adequacy of Glycaemic Control in Treatment-Naive Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study
    Tsimihodimos, Vasilis
    Bargiota, Alexandra
    Pagkalos, Emmanouil M.
    Manes, Christos
    Papas, Aggelos
    Karamousouli, Eugenia
    Voss, Bernd
    Elisaf, Moses S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2020, 128 (04) : 224 - 230
  • [38] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
    Moran, Jason
    Yeh, Helen
    Katz, Arie
    DIABETES, 2015, 64 : A315 - A315
  • [39] Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens
    Yeh, H.
    Katz, A.
    DIABETOLOGIA, 2015, 58 : S357 - S357
  • [40] Effect of prior treatment status on the efficacy and safety of ipilimumab monotherapy in treatment-naive and previously treated patients with advanced melanoma
    Thompson, J. A.
    Berman, D.
    Siegal, J.
    Minor, D.
    Amin, A.
    Ron, I.
    Ridolfi, R.
    Assi, H.
    Hamid, O.
    Weber, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345